期刊文献+

Development of a UPLC–MS/MS method for determination of pimavanserin tartrate in rat plasma: Application to a pharmacokinetic study

Development of a UPLC–MS/MS method for determination of pimavanserin tartrate in rat plasma: Application to a pharmacokinetic study
下载PDF
导出
摘要 A simple, rapid and sensitive method based on an ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) has been developed and validated for the determination of pimavanserin in rat plasma. The analyte was extracted by protein precipitation with methanol and separated on an ACQUITY BEH C18 column (100 mm × 2.1 mm, 1.7μm; Waters, USA), with an isocratic elution of acetonitrile-water containing 10 mM ammonium acetate (70:30, v/v), at a flow rate of 0.2 mL/min for 2.5 rain. The analyte and clarithromyein (the internal standard) were detected and quantified in positive ion mode using multiple reaction monitoring transitions at m/z 428.2 - 223.0 for pimavanserin and m/z 748.5 - 589.5 for clarithromycin. Relative coefficient (r) for the calibration curve was more than 0.9980. The intra-day and inter-day precisions (relative standard deviation, RSD%) were less than 13.3% and 10.5%, respectively, and the accuracy (relative error, RE%) was within ± 11.5%. The analytical method was successfully applied to a routine pharmacokinetic study of pimavanserin in rats after oral administration at the dose of 10 mg/kg. A simple, rapid and sensitive method based on an ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) has been developed and validated for the determination of pimavanserin in rat plasma. The analyte was extracted by protein precipitation with methanol and separated on an ACQUITY BEH C18 column (100 mm × 2.1 mm, 1.7μm; Waters, USA), with an isocratic elution of acetonitrile-water containing 10 mM ammonium acetate (70:30, v/v), at a flow rate of 0.2 mL/min for 2.5 rain. The analyte and clarithromyein (the internal standard) were detected and quantified in positive ion mode using multiple reaction monitoring transitions at m/z 428.2 - 223.0 for pimavanserin and m/z 748.5 - 589.5 for clarithromycin. Relative coefficient (r) for the calibration curve was more than 0.9980. The intra-day and inter-day precisions (relative standard deviation, RSD%) were less than 13.3% and 10.5%, respectively, and the accuracy (relative error, RE%) was within ± 11.5%. The analytical method was successfully applied to a routine pharmacokinetic study of pimavanserin in rats after oral administration at the dose of 10 mg/kg.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS CSCD 2017年第6期406-410,共5页 药物分析学报(英文版)
基金 supported in part by a grant of the Scientific Research Program of Hainan Province (ZDYF2016143), China
关键词 UPLC-MS/MS Pimavanserin PHARMACOKINETICS Rat plasma UPLC-MS/MS Pimavanserin Pharmacokinetics Rat plasma
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部